Long-Term Debt: leaptx.com (LPTX)

Brandmark of Leap Therapeutics Inc (LPTX)

Leap Therapeutics, Inc. (LPTX) relies on a fabless business model, outsourcing compound synthesis and clinical trials to external contractors. This daily price chart on the GURU.Markets platform captured the 0.00 metric. The company develops targeted therapies for esophageal and gastric tumors using the DKN-01 antibody; however, research expenditures result in liquidity deficits and a continuous need for external financing.

LPTX (Leap Therapeutics) Company Long-Term Debt history from 07/04/2022 to 11/13/2025

Leap Therapeutics - analytical breakdowns and key metrics (LPTX)

- current quotes and average value forecast:
Stock Quotes Leap Therapeutics Inc|LPTX - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Leap Therapeutics|LPTX - Total Company Value
- book capitalization data:
Net Assets per Single Share Leap Therapeutics|LPTX - Company Book Value|Market-to-Book Ratio leaptx.com|LPTX - Company Total Assets
- debt level and financial liquidity data:
Debt to Capital Ratio Leap Therapeutics, Inc.|LPTX - Long-Term Debt to Equity Ratio|Current Liabilities to Capital Leap Therapeutics Inc|LPTX - Company Total Debt|Debt to Net Assets Ratio Leap Therapeutics|LPTX - Company Long-Term Debts|Short-Term Debt Volume Leap Therapeutics|Quick Liquidity Indicator leaptx.com
- net income and valuation multiples indicators:
LPTX - Company Net Income
Fundamental company valuation:Leap Therapeutics, Inc.
Core merchandise of leaptx.com

Leap Therapeutics, Inc. (LPTX) oncology drug development is independent of macroeconomic cycles, making the company's capital structure a critical factor for its survival. Monitoring the organization's long-term financial debt allows for a real-time assessment of credit obligations with maturities exceeding one year, determining the balance between R&D investments and the risk of excessive debt leverage.

Who Leap Therapeutics, Inc. competes with

IBRX - Company Long-Term Liabilities|IMCR - Company Long-Term Debt|Long-Term Debt Janux Therapeutics Inc|Arcus Bio (RCUS) - Company Long-Term Debt|ZYME (Zymeworks Biopharmaceuticals) - Company Long-Term Debt|Company Long-Term Debt Tango Therapeutics|Long-Term Debt iovance.com IOVA|Company Long-Term Debts IMTX|Xencor Inc (XNCR) - Long-Term Indebtedness|Compass Bio - Company Long-Term Liabilities|Replimune Inc. (REPL) - Long-Term Debt|LYEL: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings IPHA (innate-pharma.com)|PYXS: Company Long-Term Debts|CGEN - Long-Term Debt Volume|Company Long-Term Debt IO Biotech Corp|Company Long-Term Liabilities Sutro Biopharma, Inc (STRO)|Company Long-Term Debt MiNK Therapeutics, Inc. (INKT)|Company Long-Term Liabilities werewolftx.com HOWL|Immix Biopharma - Company Long-Term Liabilities|Company Long-Term Debts alxoncology.com ALXO|CUE - Company Long-Term Debt|PDSB (PDS Biotechnology) - Company Long-Term Indebtedness|sonnetbio.com (SONN) - Company Long-Term Debt|Long-Term Debt MAIABiotech.com (MAIA)|Company Long-Term Liabilities LIMN|LVTX - Long-Term Indebtedness|Company Long-Term Liabilities NXTC (NextCure Corp)|Amount of Long-Term Liabilities INTS|Company Long-Term Debts SNSE (Sensei Biotherapeutics, Inc.)|Company Long-Term Loans and Borrowings TOVX|Gritstone Bio - Company Long-Term Debts|Long-Term Debt Kineta Inc|NexImmune Corp (NEXI) - Company Long-Term Debt|Turnstone Biologics Corp. - Company Long-Term Loans and Borrowings|VCNX (Vaccinex, Inc.) - Company Long-Term Debts|Company Long-Term Debts harpoontx.com